F062 Making the Most of Health Information Technology: Tools for the Dermatology Practice
DESCRIPTION
Health information technology (IT) capabilities are rapidly evolving and presenting unique opportunities and challenges for dermatology practices. This session will highlight advances in health IT that impact practice and physician workflows as well as the patient experience and explore their implications and applicability.
Topics to Be Covered:
1. Updates in EHR use for optimizing patient care: Explore embedded tools that go beyond documentation of the patient encounter to streamline care delivery
2. Digital imaging: Review the latest in digital imaging devices and technology that support high quality dermatologic care
3. Patient engagement: Present an overview of available resources to build an online presence and connect with patients
4. Clinical staff tools: Highlight health IT tools that optimize staff workload and efficiency
LEARNING OBJECTIVES
Identify recent advances in health IT as they relate to EHR capabilities, digital imaging, patient engagement, and support staff tools
Explore feasibility of applying health IT solutions to dermatology practices
Describe the barriers and challenges of integrating evolving health IT solutions into current practice
DIRECTOR
Milad Eshaq, MD, FAAD
CO-DIRECTOR
Justin Ko, MD, MBA, FAAD
SPEAKERS
Jane Margaret Grant-Kels, MD, FAAD
Ryan Walter Hick, MD, FAAD
Faranak Kamangar, MD, FAAD
Angela Lamb, MD, FAAD
Trilokraj Tejasvi, MD, MBBS
DISCLOSURES
Milad Eshaq, MD, FAAD
No financial relationships exist with ineligible companies.
Jane Margaret Grant-Kels, MD, FAAD
No financial relationships exist with ineligible companies.
Ryan Walter Hick, MD, FAAD
PP Capital – Stockholder(No Compensation Received); Sonic Healthcare – Stockholder(No Compensation Received); Stingray Therapeutics – Stockholder(No Compensation Received);
Faranak Kamangar, MD, FAAD
No financial relationships exist with ineligible companies.
Justin Ko, MD, MBA, FAAD
AbbVie – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant(Fees); Enspectra Health – Consultant(Fees); Google Research – Investigator(Grants/Research Funding); Hims – Consultant(Fees); Orlucent – Investigator(Grants/Research Funding); Pfizer Inc. – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Sanofi – Consultant (1099 relationship)(Fees); Skin Analytics – Consultant(Fees);
Angela Lamb, MD, FAAD
No financial relationships exist with ineligible companies.
Trilokraj Tejasvi, MD, MBBS
No financial relationships exist with ineligible companies.